The Valley Desk

NCT05345002 · Interventional trial

All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma

Overall registry status Recruiting

Phase 2

Conditions Astrocytoma, Glioma, IDH Mutation, Oligodendroglioma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov